Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cancer vaccines
Aug 12, 2020
Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck
Jun 18, 2020
Worldwide Human Papillomavirus (HPV) Vaccines Overview 2020 - Pipeline & Marketed Vaccines, Regulatory Events, Clinical Trial Landscape, Future Trends, KOL Insights, Unmet Needs, Sales (2015-2024)
Jun 18, 2020
Worldwide DNA Vaccine Market (2020 to 2022) - Increasing Focus on Genetic Vaccine Development
Jun 16, 2020
U.S. Genital Warts Market Analysis, 2017-2030 - Epidemiology, Drugs, Therapies, Vaccines, Companies, Unmet Needs, Reimbursement
Jun 09, 2020
Global Neoantigen Cancer Vaccines Market to Exhibit a CAGR of ~35% During 2020-2025
Mar 25, 2020
WHO Officials Indicating at Least 20 Vaccines in Development in Global Race for a Cure
Feb 26, 2020
Nouscom Strengthens Its Management Team
Feb 07, 2020
Disease Analysis: Human Papillomavirus (HPV) Vaccines
Jan 14, 2020
The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 34.69% during the forecast period, 2023-2030
Jan 14, 2020
Global Neoantigen Cancer Vaccine Market Study, 2023-2030: Projecting a CAGR of 34.69%; Generating Revenues of $227.1M in 2023 and $1.82B in 2030
Dec 18, 2019
Dendreon Signs Union City Lease Agreement
Nov 21, 2019
Elios Therapeutics Presents Primary Analysis of Phase IIb Study Showing Personalized Cancer Vaccine Significantly Reduces Risk of Melanoma Recurrence in High-Risk Patients
Nov 07, 2019
Trovagene Announces Third Quarter 2019 Results and Highlights
Nov 07, 2019
Civis Analytics Kicks off "Voice of the Patient" Research Series with New Studies on Telehealth and HPV Vaccination
Sep 10, 2019
Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo's DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer
Aug 22, 2019
Global Cervical Cancer Vaccines Market to Surpass US$ 6 Billion by 2026
Aug 19, 2019
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
May 30, 2019
Orion Biotechnology's Chief Medical Officer to Present at the American Society of Clinical Oncology (ASCO) Meeting in Chicago
Apr 17, 2019
Inovio's Phase 3 HPV Immunotherapy Selected As "Best Therapeutic Vaccine" at World Vaccine Congress
Apr 02, 2019
With Safety Analysis Complete, Roswell Park Moves Forward With Expanded Study of CIMAvax
Page 1
››
Latest News
Apr 26, 2024
OpenGate Capital Completes Sale of SMAC
Apr 26, 2024
Masonite Shareholders Approve Transaction with Owens Corning
Apr 26, 2024
Avery Dennison Increases Quarterly Dividend
Apr 26, 2024
ComEd Joins Bronzeville Community to Unveil New Public EV Chargers
Apr 26, 2024
OCOchem Advances Hydrogen Formate Electrolyzer Process By 10x To Create World’s Largest Industrial Scale CO2...
Apr 26, 2024
Canada Tractors Industry Analysis & Forecasts 2023-2024 and 2029: Technological Advancements and Shift...
Apr 26, 2024
Global and Regional Aircraft Fuel Cells Industry Research 2023-2033: Integration into Aircraft Systems Drives...
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events